The Effects of HMB, ATP, and HMB Plus ATP on Muscle Mass, Strength, and Power in Resistance Trained Athletes
Launched by METABOLIC TECHNOLOGIES INC. · Jan 9, 2012
Trial Information
Current as of July 05, 2025
Completed
Keywords
ClinConnect Summary
In a randomized and double blind study the subjects will consume either placebo supplements, HMB supplement, ATP supplement, or HMB plus ATP supplements for 12 weeks. While consuming the supplements the subjects will undergo an extensive resistance training program designed to train all major muscle groups. An additional overreaching training cycle during weeks 9 and 10 which will involve a high-volume, hypertrophy style training program.
Subject testing will consist of the following:
* Strength and power at weeks 0, 1, 4, 8, 9, 10, and 12
* Range of motion and muscle soreness at weeks 0,...
Gender
MALE
Eligibility criteria
- • Subjects must meet all of the inclusion criteria to participate in the study.
- • Have 3 years minimum of free weight training experience
- • Can squat a minimum of 1.5 times their bodyweight
- • Can bench press a minimum equal to their bodyweight
- • Can deadlift a minimum of 1.5 times their bodyweight
- • Are free of musculoskeletal injuries
- • Have not taken creatine or HMB supplements for 6 weeks
- • Are not taking amino acid supplements
- • Are not using anabolic or catabolic hormones
- • Are not taking medications that may interfere with study measurements
- • Are not users of tobacco products
- • All candidates meeting any one of the exclusion criteria will not be enrolled into the study.
- • Do not have 3 years minimum of free weight training experience
- • Can not squat a minimum of 1.5 times their bodyweight
- • Can not bench press a minimum equal to their bodyweight
- • Can not deadlift a minimum of 1.5 times their bodyweight
- • Are not free of musculoskeletal injuries
- • Have not taken creatine or HMB supplements in the past 6 weeks
- • Are currently taking amino acid supplements
- • Are using anabolic or catabolic hormones
- • Are taking medications that may interfere with study measurements
- • Use of tobacco products
About Metabolic Technologies Inc.
Metabolic Technologies Inc. is a pioneering biotechnology company dedicated to advancing metabolic health through innovative research and development of therapeutic solutions. With a focus on harnessing the potential of metabolic pathways, the company conducts rigorous clinical trials aimed at addressing metabolic disorders and enhancing overall well-being. Committed to scientific excellence and patient-centric approaches, Metabolic Technologies Inc. collaborates with leading researchers and healthcare professionals to translate cutting-edge discoveries into effective treatments that improve quality of life for individuals affected by metabolic conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Trial Officials
John A Rathmacher, PhD
Study Director
Metabolic Technologies Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials